Senator John Fetterman's sustained recovery from his 2022 stroke and subsequent depression treatment underpins the 79.5% implied probability on "No" for him vacating his Pennsylvania Senate seat by December 31, 2026. Since returning to Capitol Hill in early 2023, Fetterman has maintained a consistent voting record, public appearances, and committee work, with no recent health disclosures suggesting impairment. In late 2024 interviews, he reaffirmed plans for a 2028 reelection bid, signaling long-term commitment amid stable physical condition evidenced by weight loss and active engagement on issues like Israel policy. Absent new medical events, traders view early departure—via resignation or otherwise—as low-risk, reflecting crowd wisdom on his operational fitness through term's midpoint.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · AktualisiertJa
Ja
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Markt eröffnet: Nov 14, 2025, 7:17 PM ET
Resolver
0x65070BE91...An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Senator John Fetterman's sustained recovery from his 2022 stroke and subsequent depression treatment underpins the 79.5% implied probability on "No" for him vacating his Pennsylvania Senate seat by December 31, 2026. Since returning to Capitol Hill in early 2023, Fetterman has maintained a consistent voting record, public appearances, and committee work, with no recent health disclosures suggesting impairment. In late 2024 interviews, he reaffirmed plans for a 2028 reelection bid, signaling long-term commitment amid stable physical condition evidenced by weight loss and active engagement on issues like Israel policy. Absent new medical events, traders view early departure—via resignation or otherwise—as low-risk, reflecting crowd wisdom on his operational fitness through term's midpoint.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen